name of work: online tender for the rate contract and supply of pharmaceuticals to various hospitals of government of madhya pradesh - doxorubicin (lyophilised) (50mg vial), injection, tablet indomethacin 25 mg, injection ropivacaine 0.5% (5 mg/ml), injection sugammadex 100 mg./ml (rate should be quoted per/ml), tablet praziquantel 600 mg, tablet valganciclovir 450 mg, tablet valacyclovir 500 mg, tablet er prazosin 2.5 mg, tablet er prazosin 5 mg, tablet nimodipine 30 mg, tablet dabigatran 150 m

Madhya Pradesh Public Health Services Corporation Limited has invited bids for the name of work: online tender for the rate contract and supply of pharmaceuticals to various hospitals of government of madhya pradesh - doxorubicin (lyophilised) (50mg vial), injection, tablet indomethacin 25 mg, injection ropivacaine 0.5% (5 mg/ml), injection sugammadex 100 mg./ml (rate should be quoted per/ml), tablet praziquantel 600 mg, tablet valganciclovir 450 mg, tablet valacyclovir 500 mg, tablet er prazosin 2.5 mg, tablet er prazosin 5 mg, tablet nimodipine 30 mg, tablet dabigatran 150 mg, tablet rivaroxaban 10 mg, tablet isosorbide mononitrate sr 30 mg, tablet metolazone 5 mg, capsule calcitriol 0.25 mcg, tablet cabergoline 0.25 mg, tablet fludrocortisone 100 mcg, nasal spray beclomethasone 50 mcg/dose, nasal spray budesonide 64 mcg/dose, tablet tolvaptan 15 mg, capsule thalidomide 100 mg, injection sodium valproate 100 mg/ml, tablet vigabatrin 500 mg, tablet clobazam 5 mg, tablet lacosamide 50 mg, tablet baclofen 10 mg, eye drops brimonidine 0.1% w/v, ophthalmic viscoelastic hydroxypropyl methylcellulose 2% w/v 5 ml, tablet quetiapine 100 mg, tablet sr bupropion 150 mg, oral solution morphine 10 mg/5 ml, tablet propylthiouracil 50 mg, ear drops neomycin + polymyxin b + hydrocortisone neomycin 3400 units/ml + polymyxin b 10000 units/ml + hydrocortisone 10 mg/ml, ear drops acetic acid 2% w/v, injection mesna 1000 mg/10ml., tablet pramipexole 0.5 mg, eye drops loteprednol 0.5% w/v, ophthalmic viscoelastic sodium hyaluronate 1.4% w/v (rate should be quoted 0.5ml), ophthalmic irrigation solution balanced salt solution (bss) 500 ml, eye drops timolol + brimonidine + brinzolamide 0.5%+0.2%+1%, tablet clopidogrel + aspirin 75 mg + 75 mg, injection dextrose 5% + 0.45% nacl 500 ml, injection sodium chloride 0.45% (1/2 ns) 100 ml, injection hyaluronidase 1500 iu, injection rocuronium 10 mg/ml, injection cefepime 1 g, injection ifosfamide + mesna 1 g + 200 mg/2 ml, injection epirubicin 50 mg, injection asparaginase 10000 units, injection leucovorin 10 mg/ml, injection leuprolide 11.25 mg, injection paclitaxel 300 mg, injection terlipressin 100 mcg/ml, nasal drops oxymetazoline 0.05% w/v, injection octreotide 100 mcg, eye drops tobramycin + dexamethasone 0.3% + 0.1%, eye drops sodium hyaluronate 0.1% w/v, ear drops sodium bicarbonate 5% w/v, eye drops natamycin 5% w/v, doxorubicin (lyophilized ) 10 mg / vial, 5- fluro uracil ( 500 mg ) injection, injection human normal immunoglobulin (ivig) 2.5 g, eye ointment chloramphenicol + polymyxin b + dexamethasone 1% + 5000 iu + 0.1%, eye drops sodium chloride 5% w/v, eye drops proparacaine 0.5% w/v, eye drops cyclopentolate 1% w/v, eye drops ketorolac 0.5% w/v, eye drops nepafenac 0.3% w/v, eye drops latanoprost 0.005% w/v, eye drops moxifloxacin + prednisolone 0.5% + 1%, eye drops dorzolamide 2% w/v, eye drops bromfenac 0.09% w/v, eye drops hypromellose 0.3% w/v, ofloxacin 0.3% w/v ( 5ml vial ) eye /ear drop, injection somatostatin 3 mg, injection dexmedetomidine 200 mcg/2 ml, injection phenobarbitone 200 mg/ml, injection ephedrine 30 mg/ml, eye drops brinzolamide 1% w/v, injection clonazepam 1 mg/ml, cisplatin(10 mg),injection, clopidogrel (75mg) + aspirin(75mg tab),tablet, diphtheria antitoxin 10000 iu(10ml vial),injection, hydroxyurea 100mg tab/caps, linezolid 200mg/100ml (100ml ffs bottle), injection, uetiapine(100 mg),tablet, tropicamide + phenylephrine eye drop 0.8% and 5%(5 ml vial), eye drop, vasopressin(20 iu / ml),injection for a period of 18 months., with an EMD of ₹0.02 Cr. Please refer to the tender document for project value details. Interested bidders can submit applications until 5 October 2026, with the technical opening scheduled for 6 October 2026.